Metacrine Inc. (MTCR): Price and Financial Metrics
MTCR Price/Volume Stats
| Current price | $0.58 | 52-week high | $0.59 |
| Prev. close | $0.59 | 52-week low | $0.30 |
| Day low | $0.58 | Volume | 83,800 |
| Day high | $0.59 | Avg. volume | 225,834 |
| 50-day MA | $0.56 | Dividend yield | N/A |
| 200-day MA | $0.49 | Market Cap | 24.75M |
MTCR Stock Price Chart Interactive Chart >
Metacrine Inc. (MTCR) Company Bio
Metacrine, Inc. is a clinical-stage biopharmaceutical company that engages in the discovery and development of differentiated therapies for patients with liver and gastrointestinal diseases. Its farnesoid X receptor, or FXR, is central to modulating liver and GI diseases. The company was founded by Ronald M. Evans, Richard A. Heyman, and Michael Downes in 2014 and is headquartered in San Diego, CA.
MTCR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | 7.93% |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | 0.00% |
| 2022 | -33.57% |
| 2021 | -91.42% |
| 2020 | N/A |
Loading social stream, please wait...